The novel coronavirus pneumonia epidemic is still in the world, and the strain of the strain is the main epidemic strain. The national health and Health Committee and the State Administration of traditional Chinese medicine jointly issued the "New Coronavirus pneumonia diagnosis and treatment plan (trial version ninth)". New adjustments have been made to case finding and reporting procedures, case treatment and antiviral treatment, and the contents of Chinese medicine have been revised and improved. Optimize case discovery and reporting procedures The new diagnosis and treatment plan adds antigen detection as a supplement on the basis of nucleic acid detection, so as to further improve the ability of early detection of cases. According to the plan, suspected cases or those with positive antigen test results shall be subject to nucleic acid test immediately or transferred to qualified superior medical institutions for nucleic acid test. Those whose nucleic acid test results are positive shall be subject to centralized isolation management or sent to designated hospitals for treatment, and shall be directly reported online in accordance with the regulations. Li Jinming, deputy director of the clinical testing center of the National Health Commission, said that nucleic acid testing is still the "gold standard" for determining neocoronavirus infection, and antigen testing cannot replace nucleic acid testing. Cases were treated by classification According to the opinions of "patients with Omicron variant virus are mainly asymptomatic infected and light cases, most of them do not need too much treatment, and all of them will occupy a lot of medical resources in designated hospitals", the scheme further improves the case classification and treatment measures. Light cases shall be subject to centralized isolation management, and relevant centralized isolation places shall not isolate inbound personnel, close contacts and other people at the same time. During isolation management, symptomatic treatment and condition monitoring shall be done well. If the condition is aggravated, it shall be transferred to the designated hospital for treatment; Ordinary, severe and dangerous cases and cases with severe high-risk factors should be treated in designated hospitals. Among them, severe and dangerous cases should be treated in ICU as soon as possible, and patients with high-risk factors and severe tendency should also be treated in ICU. Further standardize antiviral treatment Two specific anti COVID-19 drugs approved by the State Administration of drug administration were written into the diagnosis and treatment plan, namely, PF-07321332/ Ritonavir Tablets (Paxlovid) and domestic monoclonal antibody (Alba monoclonal antibody / romicwell monoclonal antibody injection). The content of traditional Chinese medicine treatment was revised and improved Relevant experts said that the scheme combined with local clinical treatment experience, strengthened the application of traditional Chinese medicine non drug therapy and increased the content of acupuncture and moxibustion treatment; Combined with the characteristics of children's patients, add relevant contents of children's traditional Chinese medicine treatment. Adjust the release of isolation management, discharge standards and subsequent precautions According to the introduction, relevant domestic studies show that when the nucleic acid CT value of the convalescent infected person is ≥ 35, the virus cannot be isolated from the sample, and the close contacts have not been found to be infected. Accordingly, The new version of the diagnosis and treatment plan will be released from the isolation management and the discharge standard of "two consecutive respiratory tract specimens with negative nucleic acid detection (sampling time interval of at least 24 hours)" was revised to "two consecutive New Coronavirus nucleic acid detection N genes and ORF gene Ct values were all equal to 35 (fluorescent quantitative PCR method, the threshold value was 40, and the sampling time was at least 24 hours). Or for two consecutive times, the New Coronavirus nucleic acid test was negative (fluorescent quantitative PCR method, the threshold value was below 35, and the sampling time was at least 24 hours). In addition, the plan revised "14 days of isolation management and health status monitoring after discharge" to "7 days of home health monitoring after release of isolation management or discharge". (outlook new era)